Therapeutic innovations in endocrine diseases - Part 5: Rituximab and graves' orbitopathy
- PMID: 27242209
- DOI: 10.1016/j.lpm.2016.05.010
Therapeutic innovations in endocrine diseases - Part 5: Rituximab and graves' orbitopathy
Abstract
The use of rituximab in Graves' orbitopathy is appealing but its exact role in the therapeutic arsenal remains to be clarified, and its safety profile also needs to be confirmed on a larger scale.
Copyright © 2016 Elsevier Masson SAS. All rights reserved.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
